These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 26548298)
21. Community-acquired Pseudomonas aeruginosa urinary tract infections in children hospitalized in a tertiary center: relative frequency, risk factors, antimicrobial resistance and treatment. Marcus N; Ashkenazi S; Samra Z; Cohen A; Livni G Infection; 2008 Oct; 36(5):421-6. PubMed ID: 18795227 [TBL] [Abstract][Full Text] [Related]
22. Bronchiolitis obliterans organizing pneumonia associated with pseudomonas aeruginosa infection. Akbar DH; Alamoudi OS Saudi Med J; 2000 Nov; 21(11):1081-4. PubMed ID: 11360075 [TBL] [Abstract][Full Text] [Related]
23. Intensive care unit-acquired pneumonia due to Pseudomonas aeruginosa with and without multidrug resistance. Fernández-Barat L; Ferrer M; De Rosa F; Gabarrús A; Esperatti M; Terraneo S; Rinaudo M; Li Bassi G; Torres A J Infect; 2017 Feb; 74(2):142-152. PubMed ID: 27865895 [TBL] [Abstract][Full Text] [Related]
24. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience. Tennenberg AM; Davis NB; Wu SC; Kahn J Curr Med Res Opin; 2006 May; 22(5):843-50. PubMed ID: 16709306 [TBL] [Abstract][Full Text] [Related]
25. Ceftolozane-tazobactam for the treatment of multidrug-resistant Alessa MA; Almangour TA; Alhossan A; Alkholief MA; Alhokail M; Tabb DE Am J Health Syst Pharm; 2018 May; 75(9):e184-e188. PubMed ID: 29691260 [TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics of pneumonia in bedridden patients receiving home care: a 3-year prospective observational study. Ishida T; Tachibana H; Ito A; Ikeda S; Furuta K; Nishiyama A; Noyama M; Tokioka F; Yoshioka H; Arita M J Infect Chemother; 2015 Aug; 21(8):587-91. PubMed ID: 26026661 [TBL] [Abstract][Full Text] [Related]
27. [Community-acquired Pseudomonas aeruginosa bacteremic pneumonia in a "healthy" subject]. Illinger J; Mohammedi I; Martin O; Argaud L; St Denis M; Robert D Presse Med; 2003 Jul; 32(24):1123. PubMed ID: 12947742 [No Abstract] [Full Text] [Related]
28. [Guidelines for the epidemiology, diagnosis, antimicrobial therapy and management of community-acquired pneumonia and lower respiratory tract infections in adults]. Höffken G; Lorenz J; Kern W; Welte T; Bauer T; Dalhoff K; Dietrich E; Ewig S; Gastmeier P; Grabein B; Halle E; Kolditz M; Marre R; Sitter H Dtsch Med Wochenschr; 2010 Feb; 135(8):359-65. PubMed ID: 20166002 [No Abstract] [Full Text] [Related]
29. [Analysis of clinical features and outcome of nosocomial pneumonia caused by Pseudomonas aeruginosa]. Baĭgozina EA Klin Med (Mosk); 2009; 87(6):57-9. PubMed ID: 19670720 [TBL] [Abstract][Full Text] [Related]
30. A score to predict Pseudomonas aeruginosa infection in older patients with community-acquired pneumonia. Wijit K; Sonthisombat P; Diewsurin J BMC Infect Dis; 2023 Oct; 23(1):700. PubMed ID: 37858082 [TBL] [Abstract][Full Text] [Related]
31. Community-acquired pneumonia with risk for drug-resistant pathogens. Fleming V; Buck B; Nix N; Kumar P; Southwood R South Med J; 2013 Mar; 106(3):209-16. PubMed ID: 23462490 [TBL] [Abstract][Full Text] [Related]
32. Community-acquired bacteremic Pseudomonas pneumonia in a health adult. Hoogwerf BJ; Khan MY Am Rev Respir Dis; 1981 Jan; 123(1):132-4. PubMed ID: 6779684 [TBL] [Abstract][Full Text] [Related]
33. Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia. Kamata K; Suzuki H; Kanemoto K; Tokuda Y; Shiotani S; Hirose Y; Suzuki M; Ishikawa H J Infect Chemother; 2015 Aug; 21(8):596-603. PubMed ID: 26070781 [TBL] [Abstract][Full Text] [Related]
34. Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp. Moon SY; Peck KR; Chang HH; Kim SW; Heo ST; Son JS; Ryu SY; Moon C; Jung SI; Shin SY; Lee JA; Joung MK; Chung DR; Kang CI; Song JH Microb Drug Resist; 2012 Dec; 18(6):562-6. PubMed ID: 22775562 [TBL] [Abstract][Full Text] [Related]
35. A five-year review of Pseudomonas aeruginosa bacteremia in children hospitalized at a single center in southern China. Zhang Q; Smith JC; Zhu Q; Guo Z; MacDonald NE Int J Infect Dis; 2012 Aug; 16(8):e628-32. PubMed ID: 22709682 [TBL] [Abstract][Full Text] [Related]
36. [Bacterial meningitis and Pseudomonas aeruginosa: apropos of a case]. Batlle Almodóvar Mdel C; Dickinson F; Pérez Monrás M; Tamargo Martínez I; Similis A Rev Cubana Med Trop; 2005; 57(3):230-2. PubMed ID: 17969281 [TBL] [Abstract][Full Text] [Related]
37. Ceftolozane/tazobactam for the treatment of serious Pseudomonas aeruginosa infections: a multicentre nationwide clinical experience. Bassetti M; Castaldo N; Cattelan A; Mussini C; Righi E; Tascini C; Menichetti F; Mastroianni CM; Tumbarello M; Grossi P; Artioli S; Carannante N; Cipriani L; Coletto D; Russo A; Digaetano M; Losito AR; Peghin M; Capone A; Nicolè S; Vena A; Int J Antimicrob Agents; 2019 Apr; 53(4):408-415. PubMed ID: 30415002 [TBL] [Abstract][Full Text] [Related]
38. Non-nosocomial healthcare-associated left-sided Pseudomonas aeruginosa endocarditis: a case report and literature review. Hagiya H; Tanaka T; Takimoto K; Yoshida H; Yamamoto N; Akeda Y; Tomono K BMC Infect Dis; 2016 Aug; 16(1):431. PubMed ID: 27543116 [TBL] [Abstract][Full Text] [Related]
39. A case of necrotizing scleritis resulting from Pseudomonas aeruginosa. Moreno Honrado M; del Campo Z; Buil JA Cornea; 2009 Oct; 28(9):1065-6. PubMed ID: 19724201 [TBL] [Abstract][Full Text] [Related]
40. Fulminant community-acquired pneumonia probably caused by Acinetobacter lwoffii. Toyoshima M; Chida K; Suda T Respirology; 2010 Jul; 15(5):867-8. PubMed ID: 20546186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]